Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for chronic neuropathic low back pain in primary care
NL-OMON36502Phase 4Withdrawn
- Sponsor
- Pfizer
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pregabalin, sponsored by Pfizer. Planned start Aug 2011; status: withdrawn.
02
Drugs
pregabalin
Beyond the preview
Go deeper on NL-OMON36502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36502.